Systemic immune‐inflammation landscape in brain metastasis needing neurosurgical resection: Analysis of 230 consecutive cases in a single center

Abstract Background Systemic immune‐inflammation states across the heterogeneous population of brain metastases are very important in the context of brain‐immune bidirectional communication, especially among the patients needing neurosurgical resection. Four blood cell ratios based on complete blood...

Full description

Bibliographic Details
Main Authors: Jia‐Wei Wang, Ke Hu, Hai‐Peng Qian, Qing Yuan, Qi Liu, Chao Ma, Liujiazi Shao, Jing‐Hai Wan
Format: Article
Language:English
Published: Wiley 2022-10-01
Series:Immunity, Inflammation and Disease
Subjects:
Online Access:https://doi.org/10.1002/iid3.694
_version_ 1818032236301123584
author Jia‐Wei Wang
Ke Hu
Hai‐Peng Qian
Qing Yuan
Qi Liu
Chao Ma
Liujiazi Shao
Jing‐Hai Wan
author_facet Jia‐Wei Wang
Ke Hu
Hai‐Peng Qian
Qing Yuan
Qi Liu
Chao Ma
Liujiazi Shao
Jing‐Hai Wan
author_sort Jia‐Wei Wang
collection DOAJ
description Abstract Background Systemic immune‐inflammation states across the heterogeneous population of brain metastases are very important in the context of brain‐immune bidirectional communication, especially among the patients needing neurosurgical resection. Four blood cell ratios based on complete blood count (CBC) test serving as prognostic biomarkers have been highlighted by previous studies, including systemic immune‐inflammation index (SII), neutrophil‐to‐lymphocyte ratio (NLR), platelet‐to‐lymphocyte ratio (PLR), and lymphocyte‐to‐monocyte ratio (LMR). However, the presurgical systemic immune‐inflammation landscape in brain metastasis needing neurosurgical resection is limited. Methods Patients with brain metastases admitted to the Department of Neurosurgery at the National Cancer Center, Cancer Hospital of Chinese Academy of Medical Sciences between January 2016 and December 2019 were included. Based on peripheral blood cell counts in CBC test before neurosurgical resection, four systemic immune‐inflammation biomarkers (SII, NLR, PLR, and LMR) were calculated. We characterized the changes of SII, NLR, PLR, and LMR in patients with brain metastasis before neurosurgical resection and the associations of these types of immune‐inflammation states with patient demographics. In parallel, the corresponding data from the relative healthy populations without systemic diseases were enrolled as the control in the present study. Results Brain metastases induced systemic immune‐inflammation perturbation, which was characterized by a significant increase in SII (p < .01) and NLR levels (p < .01) and a significant decrease in the LMR level (p < .01) in comparison with the healthy control group. Moreover, patients with male gender, less Karnofsky Performance Status (KPS) scores (<70), specific pathological subtypes, extracranial transfer, and history of both systemic and radiation therapy may have significant differences in one or more of these biomarkers, which indicated poorer systemic immune‐inflammation states. Conclusions This study provides evidence that brain metastasis is associated with perturbations in presurgical systemic immune‐inflammation states. We should pay attention to the systemic immune‐inflammation perturbations following brain metastasis in clinic, especially in the subpopulations with high risks.
first_indexed 2024-12-10T06:04:10Z
format Article
id doaj.art-6c07f46ad92e499682e485a37e0f7d9b
institution Directory Open Access Journal
issn 2050-4527
language English
last_indexed 2024-12-10T06:04:10Z
publishDate 2022-10-01
publisher Wiley
record_format Article
series Immunity, Inflammation and Disease
spelling doaj.art-6c07f46ad92e499682e485a37e0f7d9b2022-12-22T01:59:45ZengWileyImmunity, Inflammation and Disease2050-45272022-10-011010n/an/a10.1002/iid3.694Systemic immune‐inflammation landscape in brain metastasis needing neurosurgical resection: Analysis of 230 consecutive cases in a single centerJia‐Wei Wang0Ke Hu1Hai‐Peng Qian2Qing Yuan3Qi Liu4Chao Ma5Liujiazi Shao6Jing‐Hai Wan7Department of Neurosurgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing People's Republic of ChinaDepartment of Neurosurgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing People's Republic of ChinaDepartment of Neurosurgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing People's Republic of ChinaDepartment of Neurosurgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing People's Republic of ChinaDepartment of Neurosurgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing People's Republic of ChinaDepartment of Neurosurgery, The Third People's Hospital of Hefei Hefei Third Clinical College of Anhui Medical University Hefei People's Republic of ChinaDepartment of Anesthesiology, Beijing Friendship Hospital Capital Medical University Beijing People's Republic of ChinaDepartment of Neurosurgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing People's Republic of ChinaAbstract Background Systemic immune‐inflammation states across the heterogeneous population of brain metastases are very important in the context of brain‐immune bidirectional communication, especially among the patients needing neurosurgical resection. Four blood cell ratios based on complete blood count (CBC) test serving as prognostic biomarkers have been highlighted by previous studies, including systemic immune‐inflammation index (SII), neutrophil‐to‐lymphocyte ratio (NLR), platelet‐to‐lymphocyte ratio (PLR), and lymphocyte‐to‐monocyte ratio (LMR). However, the presurgical systemic immune‐inflammation landscape in brain metastasis needing neurosurgical resection is limited. Methods Patients with brain metastases admitted to the Department of Neurosurgery at the National Cancer Center, Cancer Hospital of Chinese Academy of Medical Sciences between January 2016 and December 2019 were included. Based on peripheral blood cell counts in CBC test before neurosurgical resection, four systemic immune‐inflammation biomarkers (SII, NLR, PLR, and LMR) were calculated. We characterized the changes of SII, NLR, PLR, and LMR in patients with brain metastasis before neurosurgical resection and the associations of these types of immune‐inflammation states with patient demographics. In parallel, the corresponding data from the relative healthy populations without systemic diseases were enrolled as the control in the present study. Results Brain metastases induced systemic immune‐inflammation perturbation, which was characterized by a significant increase in SII (p < .01) and NLR levels (p < .01) and a significant decrease in the LMR level (p < .01) in comparison with the healthy control group. Moreover, patients with male gender, less Karnofsky Performance Status (KPS) scores (<70), specific pathological subtypes, extracranial transfer, and history of both systemic and radiation therapy may have significant differences in one or more of these biomarkers, which indicated poorer systemic immune‐inflammation states. Conclusions This study provides evidence that brain metastasis is associated with perturbations in presurgical systemic immune‐inflammation states. We should pay attention to the systemic immune‐inflammation perturbations following brain metastasis in clinic, especially in the subpopulations with high risks.https://doi.org/10.1002/iid3.694brain metastasisimmuneinflammationneurosurgical resection
spellingShingle Jia‐Wei Wang
Ke Hu
Hai‐Peng Qian
Qing Yuan
Qi Liu
Chao Ma
Liujiazi Shao
Jing‐Hai Wan
Systemic immune‐inflammation landscape in brain metastasis needing neurosurgical resection: Analysis of 230 consecutive cases in a single center
Immunity, Inflammation and Disease
brain metastasis
immune
inflammation
neurosurgical resection
title Systemic immune‐inflammation landscape in brain metastasis needing neurosurgical resection: Analysis of 230 consecutive cases in a single center
title_full Systemic immune‐inflammation landscape in brain metastasis needing neurosurgical resection: Analysis of 230 consecutive cases in a single center
title_fullStr Systemic immune‐inflammation landscape in brain metastasis needing neurosurgical resection: Analysis of 230 consecutive cases in a single center
title_full_unstemmed Systemic immune‐inflammation landscape in brain metastasis needing neurosurgical resection: Analysis of 230 consecutive cases in a single center
title_short Systemic immune‐inflammation landscape in brain metastasis needing neurosurgical resection: Analysis of 230 consecutive cases in a single center
title_sort systemic immune inflammation landscape in brain metastasis needing neurosurgical resection analysis of 230 consecutive cases in a single center
topic brain metastasis
immune
inflammation
neurosurgical resection
url https://doi.org/10.1002/iid3.694
work_keys_str_mv AT jiaweiwang systemicimmuneinflammationlandscapeinbrainmetastasisneedingneurosurgicalresectionanalysisof230consecutivecasesinasinglecenter
AT kehu systemicimmuneinflammationlandscapeinbrainmetastasisneedingneurosurgicalresectionanalysisof230consecutivecasesinasinglecenter
AT haipengqian systemicimmuneinflammationlandscapeinbrainmetastasisneedingneurosurgicalresectionanalysisof230consecutivecasesinasinglecenter
AT qingyuan systemicimmuneinflammationlandscapeinbrainmetastasisneedingneurosurgicalresectionanalysisof230consecutivecasesinasinglecenter
AT qiliu systemicimmuneinflammationlandscapeinbrainmetastasisneedingneurosurgicalresectionanalysisof230consecutivecasesinasinglecenter
AT chaoma systemicimmuneinflammationlandscapeinbrainmetastasisneedingneurosurgicalresectionanalysisof230consecutivecasesinasinglecenter
AT liujiazishao systemicimmuneinflammationlandscapeinbrainmetastasisneedingneurosurgicalresectionanalysisof230consecutivecasesinasinglecenter
AT jinghaiwan systemicimmuneinflammationlandscapeinbrainmetastasisneedingneurosurgicalresectionanalysisof230consecutivecasesinasinglecenter